LETEDX Letermovir

EUR 173.33

600+ vendus
Prix promo

Pharmacie physique à Hong Kong, authenticité 100% garantie

Points forts

Letermovir CMV ,

Garanties de service

Expédition transfrontalièrePharmacie agrééeContrôle pharmacienGarantie authenticité

Caractéristiques

Spécification
240mg*28 comprimes
Fabricant
Bigbear Pharmaceutical Laos

Informations produit

Nom anglais
Letermovir
Nom chinois
LETEDX
Nom générique
LETEDX

Caractéristiques

Spécification
240mg*28 comprimes
Fabricant
Bigbear Pharmaceutical Laos

Détails complets

Indications

LETEDX CMV DNA , • 6 6 (HSCT) CMV [R+] (CMV) • 12 40 CMV / CMV [D+/R-] CMV

Mécanisme d’action

12.1 Mecanisme d action PREVYMIS CMV [ 12.4 ]

Pharmacologie

12 12.1 Mecanisme d action PREVYMIS (CMV) [ (12.4)] 12.2 QT , 2 , QTc 12.3 12 12 PREVYMIS (ADME) , 90% PREVYMIS 480 mg , 34,400 (16,900, 73,700) 480 mg , 100,000 (65,300,

Posologie

• (HSCT) 30 12 , 40 12 o (HSCT) , 480 , (IV) , 1 , 100 (CMV) ,LETEDX 200 o , 480 , , 1 , 200 • (HSCT) 6 12 , 12 30 o (HSCT) , , 1 , 100 (CMV) ,LETEDX 200 • LETEDX , (HSCT) CMV • LETEDX , 12 LETEDX 240 , 12 LETEDX ,

Precautions

5 Precautions PREVYMIS , PREVYMIS PREVYMIS , (4, 5.1, 7.1, 7.2, 7.3) PREVYMIS PREVYMIS , 4

Contre-indications

LETEDX • • •

Interactions médicamenteuses

7 PREVYMIS , 12 PREVYMIS 240 mg (2.4) PREVYMIS 12 , (2.6) PREVYMIS , PREVYMIS , , 2.4 2.6 4 5.1 7.1 7.2 7.3 7.4 12.3 7.1 PREVYMIS 1B1/3 (OATP1B1/3) P- (P-gp) UDP- 1A1/3 (UGT)

Effets indésirables

• (HSCT) LETEDX 10% , 2% • LETEDX 10% , •

Package Insert

Ingredients

11 PREVYMIS , (CMV) DNA , C₂₉H₂₈F₄N₄O₄, 572.55 (4S)-2-{8- -2-[4-(3- ) -1- ]-3-[2- -5-( ) ]-3,4- -4- } PREVYMIS 240 mg 480 mg

Appearance

3 240 480 (3) 20 120 (3) ,240 /12 (20 / ) 480 /24 (20 / ) (3) PREVYMIS 240 , “591”, PREVYMIS 480 , “595”, PREVYMIS , 20

Indications

LETEDX CMV DNA , • 6 6 (HSCT) CMV [R+] (CMV) • 12 40 CMV / CMV [D+/R-] CMV

Posologie

• (HSCT) 30 12 , 40 12 o (HSCT) , 480 , (IV) , 1 , 100 (CMV) ,LETEDX 200 o , 480 , , 1 , 200 • (HSCT) 6 12 , 12 30 o (HSCT) , , 1 , 100 (CMV) ,LETEDX 200 • LETEDX , (HSCT) CMV • LETEDX , 12 LETEDX 240 , 12 LETEDX ,

Effets indésirables

• (HSCT) LETEDX 10% , 2% • LETEDX 10% , •

Contre-indications

LETEDX • • •

Precautions

5 Precautions PREVYMIS , PREVYMIS PREVYMIS , (4, 5.1, 7.1, 7.2, 7.3) PREVYMIS PREVYMIS , 4

Use in Pregnancy and Lactation

8.1 PREVYMIS , , AUC (RHD) 11 , - , RHD 2 , - / , RHD 2 , ,

Interactions médicamenteuses

7 PREVYMIS , 12 PREVYMIS 240 mg (2.4) PREVYMIS 12 , (2.6) PREVYMIS , PREVYMIS , , 2.4 2.6 4 5.1 7.1 7.2 7.3 7.4 12.3 7.1 PREVYMIS 1B1/3 (OATP1B1/3) P- (P-gp) UDP- 1A1/3 (UGT)

Clinical Pharmacology

12 12.1 Mecanisme d action PREVYMIS (CMV) [ (12.4)] 12.2 QT , 2 , QTc 12.3 12 12 PREVYMIS (ADME) , AUC 90% PREVYMIS 480 mg , , 34,400 (16,900, 73,700) 480 mg , ,

Pharmacology and Toxicology

13 13.1 , , 6 RasH2 , 150 mg/kg/ , 300 mg/kg/ CMV , , AUC RHD 5 , ,

Clinical Studies

14 14.1 17 PREVYMIS HSCT 17 PREVYMIS NCT N N P001 (NCT02137772) [R+] PREVYMIS (373) (192) 14 24 CMV P040 (NCT03930615) CMV [R+] PREVYMIS (144) (74) 14 28 28 CMV P002 (NCT03443869) [D+/R-] PREVYMI

Avis produit (0)

Filtre : Tous les avis
5.0★★★★★
0 avis clients0 achats verifies
Aucun avis pour ce produit.

Description

Indications

LETEDX CMV DNA , • 6 6 (HSCT) CMV [R+] (CMV) • 12 40 CMV / CMV [D+/R-] CMV

Mécanisme d’action

12.1 Mecanisme d action PREVYMIS CMV [ 12.4 ]

Pharmacologie

12 12.1 Mecanisme d action PREVYMIS (CMV) [ (12.4)] 12.2 QT , 2 , QTc 12.3 12 12 PREVYMIS (ADME) , 90% PREVYMIS 480 mg , 34,400 (16,900, 73,700) 480 mg , 100,000 (65,300,

Posologie

• (HSCT) 30 12 , 40 12 o (HSCT) , 480 , (IV) , 1 , 100 (CMV) ,LETEDX 200 o , 480 , , 1 , 200 • (HSCT) 6 12 , 12 30 o (HSCT) , , 1 , 100 (CMV) ,LETEDX 200 • LETEDX , (HSCT) CMV • LETEDX , 12 LETEDX 240 , 12 LETEDX ,

Precautions

5 Precautions PREVYMIS , PREVYMIS PREVYMIS , (4, 5.1, 7.1, 7.2, 7.3) PREVYMIS PREVYMIS , 4

Contre-indications

LETEDX • • •

Interactions médicamenteuses

7 PREVYMIS , 12 PREVYMIS 240 mg (2.4) PREVYMIS 12 , (2.6) PREVYMIS , PREVYMIS , , 2.4 2.6 4 5.1 7.1 7.2 7.3 7.4 12.3 7.1 PREVYMIS 1B1/3 (OATP1B1/3) P- (P-gp) UDP- 1A1/3 (UGT)

Effets indésirables

• (HSCT) LETEDX 10% , 2% • LETEDX 10% , •

Informations complementaires

Specification

240mg*28片